Literature DB >> 2217529

Effects of fixed-ratio requirement on observed tolerance to decreased responding by clonidine.

J B Smith1.   

Abstract

Responding of rats was maintained under either a 10- or a 40-response fixed-ratio schedule, and "local" rates of responding were 0.29-0.37 responses per sec for both schedules. Clonidine decreased responding for both schedules in a similar and dose-dependent manner, and the largest dose tested (0.3 mg/kg) completely suppressed behavior. When 0.1 mg/kg was administered immediately prior to 30 daily experimental sessions, FR10 responding recovered to control levels within 15 sessions, whereas FR40 responding recovered only to approximately 60% of control level at asymptote. These results continue to identify boundary conditions for the influence of reinforcer loss on tolerance development, and they emphasize the overriding influence of behavioral processes on observed tolerance to the behavioral effects of drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217529     DOI: 10.1016/0091-3057(90)90112-u

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Effects of shock intensity on observed tolerance to decreased avoidance responding by clonidine.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Effects of clonidine on progressive ratio schedule performance in Fmr1 knockout mice.

Authors:  Craige C Wrenn; Eric French; Dustin Baker; Randall McCallian; Ryan Kirk; Mark P Reilly; Maria G Valdovinos
Journal:  Psychopharmacology (Berl)       Date:  2021-01-15       Impact factor: 4.530

3.  Morphine tolerance as a function of ratio schedule: response requirement or unit price?

Authors:  Christine E Hughes; Stacey C Sigmon; Raymond C Pitts; Linda A Dykstra
Journal:  J Exp Anal Behav       Date:  2005-05       Impact factor: 2.468

4.  Examination of reinforcement magnitude on the pharmacological disruption of fixed-ratio performance.

Authors:  Jonathan W Pinkston; Brett C Ginsburg; R J Lamb
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.